GermanT.HernandezMDFASN, FACP(He/Him)

[Pronunciation: hair-mahn]

Acute Renal Failure, Chronic Renal Failure & Dialysis, Glomerular Disease, Hypertension

Nephrologist & Vice President at El Paso Kidney Specialists. Clinical Associate Professor of Medicine, Texas Tech University Health Sciences Center El Paso

Join to view full profile

Dr. Hernandez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hernandez's full profile

Already have an account?

Office
111989 Pellicano Drive
Suite C
El Paso, TX 79936
Phone+1 915-857-0700

Fax+1 915-857-7495

Summary

Dr. German Hernandez is a nephrologist in El Paso, TX and is affiliated with multiple hospitals including The Hospitals of Providence, Las Palmas-Del Sol Medical Centers, and University Medical Center of El Paso. He received his medical degree from Harvard Medical School and his specialty training at UCSF. He has been in practice for 20 years. He speaks English and Spanish.

Education & Training

University of California (San Francisco)Fellowship, Nephrology, 2002 - 2004
UCSF Health2002 - 2004
University of California (San Francisco)Chief Residency, Internal Medicine, 2001 - 2002
University of California (San Francisco)Residency, Internal Medicine, 1998 - 2001
Harvard Medical SchoolClass of 1998, M.D.
Stanford UniversityBS, Biological Sciences, 1990 - 1994

Certifications & Licensure

NM State Medical License 2018 - 2027
CA State Medical License 1999 - 2025
TX State Medical License 2005 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Texas Super Doctor https://www.superdoctors.com/texas/doctor/German-Hernandez/bb4d6258-299a-4fbf-9a93-119c6709c407.html, 2013-2022
Fellow American College of Physicians
Fellow American Society of Nephrology

Clinical Trials

Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT) Start of enrollment: 2004 Nov 01
Completed
Phase 3
A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis Start of enrollment: 2006 Jan 01
Completed
Phase 3
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy Start of enrollment: 2002 Jan 01
Terminated
Phase 3
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency Start of enrollment: 2008 Jan 01
Completed
Phase 3
A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) Start of enrollment: 2008 Feb 15
Terminated
Phase 3
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Start of enrollment: 2008 Dec 01
Completed
Phase 2
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis Start of enrollment: 2012 Jul 01
Terminated
Phase 2
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease Start of enrollment: 2015 Sep 17
Completed
Phase 3
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease Start of enrollment: 2015 Sep 17
Completed
Phase 3
Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection Start of enrollment: 2015 Dec 01
Completed
Phase 3
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) Start of enrollment: 2016 Feb 01
Completed
Phase 3
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Participants With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD) Start of enrollment: 2016 Jul 01
Completed
Phase 3
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD) Start of enrollment: 2016 Aug 01
Completed
Phase 3
Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) Start of enrollment: 2023 Apr 26
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

Safety and Efficacy of Vadadustat Once Daily and Three Times Weekly in Patients With Dialysis-Dependent CKD With Anemia.
Laura Kooienga, Steven Burke, Amarnath Kathresal, Wenli Luo, Zhihui Yang
Kidney360. 2024-11-01
1 citations
Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study.
Arnold L Silva, Glenn M Chertow, German T Hernandez, Robert I Lynn, David P Tietjen
Kidney360. 2023-11-01
8 citations
An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis.
Ahmed M Awad, Adu Ntoso, Jeffrey J Connaire, German T Hernandez, Kiranjit Dhillon
Vaccine. 2021-05-14

Press Mentions

Hospitals Are Reeling Under a 46 Percent Spike in Covid-19 PatientsJuly 26th, 2022
‘It’s a Terrible Existence’: The Crisis of Emergency Dialysis Care for Undocumented ImmigrantsJuly 26th, 2022